Dr. Mesfin, an esteemed orthopedic surgeon and researcher, has been recognized for his 15 years of dedicated service to the North American Spine Society (NASS). During his tenure, Dr. Mesfin has earned two best paper nominations, served as a reviewer for the Annual Meeting abstracts, and contributed to several NASS committees, including the Section on Spine Oncology, the Research Project Management Committee, and the Patient Safety Committee.

“Dr. Mesfin has demonstrated himself to be a dedicated researcher toward the advancement of our field in the setting of basic science research as demonstrated by his accomplishments,” said Peter Passias, MD, a colleague and fellow NASS member. “This complements his clinical and outcomes-based contributions to our field. We are excited to have him receive this recognition and appreciate his dedication to our society.”

Leadership in Orthopedic Surgery

Dr. Mesfin currently serves as Vice Chair of Research and Professor of Orthopaedics at Medstar Orthopaedic Institute/Georgetown University School of Medicine. His career began at the University of Rochester, where he held prominent roles as Chief of Spine Surgery, Spine Fellowship Director, and Professor. His extensive training includes an orthopedic residency at Johns Hopkins Hospital, a Spine Surgery Fellowship at Washington University in St. Louis, and advanced spine oncology training at Kanazawa University in Japan and the Rizzoli Orthopaedic Institute in Italy.

Pioneering Research Contributions

Dr. Mesfin’s research portfolio includes over 200 peer-reviewed publications and more than 300 presentations at national and international conferences. His work, which has received grant funding, spans multiple disciplines and emphasizes collaboration in spine research. His contributions to patient safety and spine oncology have solidified his reputation as a leader in both clinical and academic settings.

With his extensive experience and continued commitment to advancing orthopedic care, Dr. Mesfin’s contributions are set to shape the future of spine surgery for years to come.